← Revolution Medicines
Episodes featuring Revolution Medicines
17 episodes, newest first.
- Nov 15, 2026
Biotech investors weigh gene editing, MASH data and RAS riskBreaking BiotechNov 15, 2026 - Nov 13, 2026
Biotech launches expose the gap between forecasts and adoptionBiotech HangoutNov 13, 2026 - Nov 12, 2026
Biotech’s uncertainty creates disciplined investment opportunitiesThe Acquirers PodcastNov 12, 2026 - Nov 9, 2026
Biotech investors weigh obesity, RAS drugs and Moderna catalystsBreaking BiotechNov 9, 2026 - Nov 6, 2026
Election stakes meet biotech’s regulatory and pipeline risksBiotech HangoutNov 6, 2026 - Oct 30, 2026
Cancer vaccine data meets market volatility at ESMOThe Readout LoudOct 30, 2026 - Oct 27, 2026
Cramer tests the data-center revival beyond AIMad Money w/ Jim CramerOct 27, 2026 - Oct 20, 2026
China reshapes biotech deals as RNAi reaches the brainBioCentury This WeekOct 20, 2026 - Oct 16, 2026
Biotech selloff tests valuations as clinical bets advanceBiotech HangoutOct 16, 2026 - Oct 14, 2026
AI leadership meets rising-rate riskTrader Talk Oct 14, 2026 - Sep 13, 2026
Biotech’s rally tests the promise of cancer breakthroughsWSJ's Take On the WeekSep 13, 2026 - Sep 1, 2026
Flood disaster and cancer breakthrough frame AM UpdateThe Megyn Kelly ShowSep 1, 2026 - Aug 28, 2026
Markets await Fed clarity as Shein cuts IPO ambitionsMorning Brew DailyAug 28, 2026 - Aug 26, 2026
Markets weigh Meta safeguards, Nvidia expectations and cancer-drug promiseStock MoversAug 26, 2026 - Aug 26, 2026
Meta settlement puts teen-platform safeguards under scrutinyWSJ What’s NewsAug 26, 2026 - Jan 21, 2026
Greenland tariff fears expose market froth and crowded tradesMad Money w/ Jim CramerJan 21, 2026 - Oct 16, 2025
Cramer weighs rate cuts against fragile speculative ralliesMad Money w/ Jim CramerOct 16, 2025